You are here: Welcome to the MPKB » Welcome to the MPKB » Science behind Marshall Paradigm » Science behind Marshall Protocol antibiotics
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:protocol:mp_antibiotics [07.23.2013] – [Science behind Marshall Protocol antibiotics] ingehome:protocol:mp_antibiotics [01.08.2014] – [Mechanisms of action] sallieq
Line 35: Line 35:
 Emerging research now suggests that antibiotics have much broader range of actions that once supposed. Emerging research now suggests that antibiotics have much broader range of actions that once supposed.
  
-N.B. azithromycin is no longer recommended for use while on the MP 
  
 ^Name   ^Action(s) ^ ^Name   ^Action(s) ^
 |Minocycline    |interferes with bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome; may bind the PXR Nuclear Receptor; inhibits activity of caspase-3    |   |Minocycline    |interferes with bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome; may bind the PXR Nuclear Receptor; inhibits activity of caspase-3    |  
-|Azithromycin (Zithromax)     |interferes with bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome;  significantly inhibited expression of co-stimulatory molecules (CD40 and CD86) and major histocompatibility complex (MHC) class II by dendritic cells; reduces toll-like receptor 4 expression, interleukin-12 production and the allostimulatory capacity of dendritic cells(({{pubmed>long:22059997}})) |+|Azithromycin (Zithromax) //no longer recommended//     |interferes with bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome;  significantly inhibited expression of co-stimulatory molecules (CD40 and CD86) and major histocompatibility complex (MHC) class II by dendritic cells; reduces toll-like receptor 4 expression, interleukin-12 production and the allostimulatory capacity of dendritic cells(({{pubmed>long:22059997}})) |
 |Clindamycin   |interferes with bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome     | |Clindamycin   |interferes with bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome     |
 |Demeclocycline (Declomycin)  |interferes with bacterial protein synthesis by binding to the 30S and 50S subunit of the bacterial ribosome     |        |Demeclocycline (Declomycin)  |interferes with bacterial protein synthesis by binding to the 30S and 50S subunit of the bacterial ribosome     |       
home/protocol/mp_antibiotics.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.